Have Questions? Want Help? 1(800)557-5693

Health Insurance, Health Care Policy, Primary Care, Health Care Reform, Prescription Drugs, Women's Health, Children's Health, Aging

Caution on New Drugs for Restless Leg Syndrome

| Email to a friend Email to a friend

You've probably seen those TV commercials for Requip (ropinirole), the first drug approved to treat "restless leg syndrome", a condition whose signature feature is creepy-crawly leg sensations that interfere with sleep and rest in nearly 1 of every 10 adults.

But if taken too long, the drug can actually backfire, causing symptoms to worsen, say doctors who specialize in treating the condition. At this point, you can't just up the dose. The drug is part of the problem. They say that treatment that rotates through different types of medications may be needed for many patients

In the wake of FDA approval for Requip and Mirapex (pramipexole), along with the attendant heavy advertising, It's important for both primary care physicians and patients alike to understand the risks of relying on these medications for too long.

About this Entry

This page contains a single entry by Phil Daigle published on December 28, 2006 8:06 PM.

Planning for Cosmetic Surgery Abroad was the previous entry in this blog.

Planning for Cosmetic Surgery Abroad is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Email Subscription


Twitter